John Robert Anderson Jr., Executive Vice President and Chief Medical Officer of Concentra Group Holdings Parent, Inc., filed a Form 4 on November 6, 2026, disclosing a tax-withholding transaction on November 4, 2026, in which 13,080 shares of common stock were withheld at $40.90 per share upon the vesting of restricted stock.

Key Highlights

  • Reporting person: John Robert Anderson Jr., Executive Vice President and Chief Medical Officer of Concentra Group Holdings Parent, Inc. (NYSE:CON)
  • Transaction date: November 4, 2026
  • Transaction code: F (shares withheld to satisfy tax obligations from restricted stock vesting)
  • Shares withheld: 13,080 shares of common stock at $40.90 per share
  • Remaining beneficial ownership: 100,380 shares of common stock held directly following the transaction

Tax Withholding Reduces Anderson's Direct Stake to 100,380 Shares

According to the filing, Anderson's transaction on November 4, 2026, was coded "F," which the filing identifies as shares of common stock withheld to satisfy tax obligations arising out of the vesting of restricted stock. The price recorded for the withheld shares was $40.90 per share. The transaction resulted in a disposition of 13,080 shares on a direct ownership basis.

Following the reported transaction, Anderson beneficially owned 100,380 shares of Concentra Group Holdings Parent, Inc. common stock directly, according to the filing. No derivative securities transactions were reported in Table II. The Form 4 was signed by Timothy F. Ryan as Attorney-in-Fact and filed on November 6, 2026.

Anderson's title is listed in the filing's remarks section as Executive Vice President, Chief Medical Officer. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934 and was filed by one reporting person. No amendment date was indicated, and the form does not check the box indicating a Rule 10b5-1(c) plan.

What Was Disclosed

The filing disclosed a single disposition transaction by an officer of Concentra Group Holdings Parent, Inc. in which 13,080 shares were withheld at $40.90 per share on November 4, 2026, to cover tax obligations from restricted stock vesting, leaving a direct holding of 100,380 shares.